Device Trial Radar · NCT03438747
P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation
Last checked: Nov 20, 2026Latest source record: Oct 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
290
Actual
Start
Apr 24, 2018
Primary completion
Feb 28, 2028
Study completion Feb 28, 2028
Sponsor
- Lead sponsor
- CeraPedics, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 20, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this trial is to evaluate if P-15L bone graft (investigational device) is not inferior in effectiveness and safety to local autologous bone (and allograft where necessary) as an extender (control device) when applied in instrumented transforaminal lumbar interbody fusion (TLIF) in subjects with degenerative disc disease (DDD). In addition to the general overall objective, a sub-group analysis will be performed on the high-risk subject population (tobacco use, obesity, diabetes), as previous studies have shown negative effects of smoking, obesity and diabetes on fusion and bone healing, increased peri/postoperative complications, and lower patient-reported outcome scores.
Conditions
- Degenerative Disc Disease
Interventions
P-15L Bone GraftDevice
The investigational group will be treated with P-15L in an instrumented TLIF
Local autologous bone in a TLIF with InstrumentationOther
The active control group will be treated local autologous bone in an instrumented TLIF
Primary outcomes
What the sponsor says the trial is designed to measure.
- Secondary surgical interventionTime frame: 72 Months
- FusionTime frame: 72 Months
- Oswestry Disability Index (ODI)Time frame: 72 Months
2 more outcomes with a free account
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
The University of Alabama at Birmingham
Birmingham, Alabama
Glendale Adventist Medical Center
Glendale, California
Keck School of Medicine USC
Los Angeles, California
31 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.